Biogenesis

Biogenesis

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://mybiogenesis.com

Last Round

Seed

Mar 1, 2024

Total Funding Raised

$2.75M

Company Overview

Biogenesis is a healthcare technology company that provides an AI-powered platform designed to accelerate clinical trials by matching pharmaceutical organizations with suitable clinical research sites.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Workflow Automation, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission

AI Layer

Application

Keywords

clinical trial platformclinical trial feasibilitysite selectionClinTechclinical trial automationresearch site networkAI copilotsite discoverypredictive site analyticssite activationstudy startuppharma techClinical Research OrganizationsCROsmedical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biogenesis Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biogenesis Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2024
Pre SeedOct 2, 2022

Biogenesis Investors

Notable investors and investment history

InvestorRounds
UC LAUNCHPre Seed
Alt CapitalSeed
Kleiner PerkinsPre Seed
NucleatePre Seed
Pareto HoldingsPre Seed
Z FellowsPre Seed
Formic VenturesPre Seed

Biogenesis Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biogenesis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biogenesis's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range16
Year Founded2022
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.